Panel Discussion: Evaluating the Different Preclinical Tumor Models & Their Applications Across Oncology Therapeutic Development
Time: 9:00 am
day: Day 2 AM
Details:
- Assessing the pros and cons of the most commonly implemented models, and sharing strategies to select the most appropriate model for your cancer study
- Discussing their contexts of use across oncology drug development and how to leverage biomarkers, and apply reverse translation to bridge the translational gap
- What impact has the FDA announcement to phase out animal testing for certain therapies had on research and the tumor modeling field?
